INTRODUCTION
The protozoan parasite Toxoplasma gondii is the infective agent responsible for Toxoplasmosis (6, 11) . Whilst in the United States it is estimated that 22.5% of the population 12 years and over have been infected, in other places in the world it has been shown that up to 95% of the population have been in contact with Toxoplasma (8) . The diffusion of the parasite is more represented in hot and humid areas with no high altitudes.
The way of infection is mainly through microscopic cysts included in food that can be transmitted by undercooked, contaminated meat or handling contaminated meat and contact with not washed hands, or by using not washed knives and utensils came in contact with infected meat. The most important role in the parasitic transmission is played by cats. Cats usually eat rodents, birds, or other small infected animals. The parasites then passed in the cat's feces in a oocyst form (21) . The passage from person to person was never evidenced, except in mother-to-child transmission (7, 17) , and blood transfusion (5, 9) or organ transplantation (4, 15) . The transplantation of an organ from a Toxoplasma-positive donor can cause the infection of the recipient, and, in some cases, bring to a severe prognosis. The most diffused surveillance for Toxoplasma infection is in mother-to-child (congenital) transmission (2, 16) . A woman who becomes positive to Toxoplasma during pregnancy can pass the infection to the fetus. The mother may not have symptoms, but severe consequences, such as miscarriage or diseases to the nervous system or to the eyes of the unborn child could arise during pregnancy or later in the infant. If the woman had a previous Toxoplasma infection before becoming pregnant, the unborn child will be protected, but she can pass the infection if the contact with the parasite is during or immediately before pregnancy. The earlier the infection is, the more severe is the damage to the unborn child. The diagnosis of Toxoplasmosis is typically made by serologic testing (12, 14) , but the molecular tech-niques that are able to detect the Toxoplasma's DNA in the amniotic fluid, or in the peripheral blood of the mother, can be very useful in cases of possible mother-to-child (congenital) transmission (18) (19) (20) .
OBJECTIVES
The aim of the present study is to introduce a new PCR-based assay for Toxoplasma detection able to identify a possible mother-to-child transmission, or an infection derived from a positive organ transplantation, or again from an infected blood transfusion with a sensitivity and a specificity at least equal to the panel of the serological gold standard and direct observation panel tests. The test involves the extraction of nucleic acids from amniotic fluid, or whole blood , or tissues, and the amplification via a simple PCR protocol. The detection is performed on electrophoretic agarose gel. The system contains an internal control to assess the functionality of the test, and to exclude PCR inhibition.
DESIGN AND METHODS
The assay is a ready-to-use test that includes all the required elements for the amplification of nucleic acid targets. Amniotic fluid or whole blood have been extracted with a convenient protocol in order to obtain good-quality DNA. For this study we used a silica based system developed internally. The extraction protocol starts with a washing step balanced on the different biological material. Then, a solution containing a chaotropic agent and a suspension of silica for binding the DNA, are added to the washed sample. The suspension is left 3-5 minutes at room temperature. A further washing step with ethanol completes the procedure. The pellet is left to dry for five minutes at room temperature, and then dissolved in 100 -200 μl of sterile water. The DNA was immediately used for the PCR protocol and then stored at -20°C. The set of primers for the amplification of Toxoplasma gondii was designed in the RE region (GenBank accession number AF146527), a repetitive sequence of 200-300 repeats in the Toxoplasma genome, giving an amplified fragment of 134 bp. In each test tube an internal control was also included. The primers for the internal control were designed in the human beta-globin gene. The choice for a housekeeping gene was done to introduce both a control of the extraction system and a control for the efficiency of the amplification. The amplified fragment corresponds to a band of 268 bp. The two sets of primers for the specific region of Toxoplasma gondii and for the internal control were designed to have the same thermal profile and to be amplified simultaneously in a multiplex format. Each test was performed using two units of Hot Start DNA Polymerase. The thermal profile of the PCR reation is described in Table 2 ). The samples were prepared starting from Toxoplasma cultures, diluted and resuspended in a matrix. The matrix was clinical amniotic fluid or plasma, previously tested serologically and by molecular techniques (PCR) to ensure negativity for T. gondii. The samples from TG08-01 to TG08-07 were dissolved in amniotic fluid. The samples from TG08-08 to TG08-10 were dissolved in plasma.
RESULTS
The panel of samples considered in the present study include strong positive as well as weak positive and negative samples. All the samples were tested in repetitive runs for the intraassay and inter-assay evaluation. Qualitative results obtained using primers specific for RE sequence were compared with the expected results of the panel.
The results showed a perfect agreement in ten out of ten samples of the panel.
Even in presence of very low levels of parasitic infection (5 parasites/ml in some samples) the developed test was able to detect the presence of Toxoplasma gondii in the sample. In the two lower concentrated samples (5 parasites/ml), the repetitions resulted positive in 50% of cases in amniotic fluid and 60% in plasma samples, indicating this concentration as a detection limit. Figure I shows the electrophoretic profile of a PCR run. All the bands corresponding to the internal control (beta-globin) are clearly amplified. The ready-to-use format avoids problems related to cross-contamination due to multi-step preparation of common PCR master mixes. In order to evaluate the specificity of the test we also used samples positive for other parasitic infections such as Leishmania and Malaria. No false positives were observed in all the checked samples. No cross -reactivity between Toxoplasma and other parasites was observed. The specificity of the test was equal to 100% ( Figure II) . 
